{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-077431","form_type":"8-K","ticker":"ISPR","cik":"0001948455","company_name":"Ispire Technology Inc.","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.113706+00:00","generated_at":"2026-06-10T14:02:30.044582+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Ispire Tech FY2023 revenue up 31% to $115.6M; cannabis vaping sales doubled; issues strong FY2024 guidance","bullets":["FY2023 revenue $115.6M (+31.2% YoY); cannabis vaping $40M (+100.4%), tobacco vaping $75.6M (+10.9%).","Gross profit $21.1M (+58.4%), margin 18.2% vs 15.1%; net loss widened to $6.1M from $1.9M.","Restatement: intangible asset corrected to nil, reducing nine-month net loss and equity.","FY2024 outlook: cannabis vaping revenue growth 100%-125% ($80M-$90M); tobacco vaping growth 25%-40% ($95M-$105M).","Q4 2023 non-GAAP net profit $0.5M vs loss of $1.9M in Q4 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-077431","json":"https://secwatch.observer/filing/0001213900-23-077431.json","markdown":"https://secwatch.observer/filing/0001213900-23-077431.md","text":"https://secwatch.observer/filing/0001213900-23-077431.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1948455/000121390023077431/0001213900-23-077431-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1948455/000121390023077431/ea185377-8k_ispiretech.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T14:02:30.044582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e1bc5bb33fa2da1f2dcee60517589fcc43dbe0b4","claim":"Ispire Technology Inc. reported the fiscal year ended June 30, 2023 results: revenue $115.6 million. Guidance raised.","evidence_excerpt":"2023 Revenue from cannabis vaping products was up 100.4% to $40 Million. Revenue from tobacco vaping products was up 10.9% to $75.6 Million. Overall Revenue Increased 31.2% to $115.6 Million Issues Fiscal Year 2024 Outlook for Cannabis Vaping Products, Representing a Potential Growth between 100% and 125%, Outlook for Tobacco Vaping Products, Representing a Potential","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1948455/000121390023077431/0001213900-23-077431-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended June 30, 2023"},{"label":"Revenue","value":"$115.6 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}